A randomized crossover study to compare continuous subcutaneous insulin infusion (CSII) with multiple daily injection (MDI) in type 1 diabetic patients previously treated with CSII

被引：0
|
作者：
Maran, A [1 ]
Crazzolara, D [1 ]
Nicoletti, M [1 ]
Costa, S [1 ]
dal Pos, M [1 ]
Tiengo, A [1 ]
Avogaro, A [1 ]
Bruttomesso, D [1 ]
机构：
[1] Cattedra Malattie Metab, Padua, Italy
来源：
DIABETOLOGIA | 2005年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
902
引用
收藏
页码：A328 / A328
页数：1
相关论文
共 50 条
  • [21] Depression and anxiety symptoms in diabetic patients on continuous subcutaneous insulin infusion (CSII)
    Reichel, A
    Schwarz, J
    Schulze, J
    Licinio, J
    Wong, ML
    Bornstein, SR
    MOLECULAR PSYCHIATRY, 2005, 10 (11) : 975 - 976
  • [22] Depression and anxiety symptoms in diabetic patients on continuous subcutaneous insulin infusion (CSII)
    A Reichel
    J Schwarz
    J Schulze
    J Licinio
    M-L Wong
    S R Bornstein
    Molecular Psychiatry, 2005, 10 : 975 - 976
  • [23] COMPARISON OF HUMAN INSULIN WITH PORCINE INSULIN - A DOUBLE-BLIND CROSSOVER STUDY IN TYPE-I DIABETIC-PATIENTS TREATED BY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII)
    SONNENBERG, GE
    CUPPERS, HJ
    CHANTELAU, E
    BERGER, M
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1982, 12 (02) : 40 - 40
  • [24] Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus
    Misso, M. L.
    Egberts, K. J.
    Page, M.
    O'Connor, D.
    Shaw, J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (01):
  • [25] Similar Estimated A1c Results Reported between Patients with Diabetes Using CGM whether on Multiple Daily Injection (MDI) or Continuous Subcutaneous Insulin Infusion (CSII)
    Nakamura, Katherine
    Ebner, Eric
    Price, David A.
    DIABETES, 2016, 65 : A21 - A21
  • [26] Switch from continuous subcutaneous insulin infusion (CSII) with insulin lispro [Humalog®]to multiple daily injections (MDI) with insulin glargine (Lantus) and insulin lispro
    Bode, B
    Schleusener, D
    Strange, P
    DIABETES, 2003, 52 : A102 - A103
  • [27] Continuous subcutaneous insulin infusion (CSII) versus multiple daily injections (MDI) of rapid-acting insulin analogues and detemir in type 1 diabetic (T1D) pregnant women
    Mello, Giorgio
    Biagioni, Sara
    Ottanelli, Serena
    Nardini, Camilla
    Tredici, Zelinda
    Serena, Caterina
    Marchi, Laura
    Mecacci, Federico
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2015, 28 (03): : 276 - 280
  • [28] Nocturnal hypoglycemia is not inevitable in type 1 diabetes patients on continuous subcutaneous insulin infusion (CSII)
    Devries, J
    Masurel, N
    Poscia, A
    Heine, R
    DIABETES, 2003, 52 : A92 - A92
  • [29] Comparison of glycemic control in 3 groups of type 1 diabetic patients treated with multiinjections and lispro (MDI), continuous subcutaneous insulin infusion with lispro (CSII) or continuous peritoneal insulin infusion (CPII): Data of continuous subcutaneous glucose sensing (CGMS)
    Meyer, L
    Boullu-Sanchis, S
    Boeckler, P
    Sibenaler, A
    Treger, M
    Pinget, M
    Jeandidier, N
    DIABETES, 2002, 51 : A124 - A125
  • [30] Impact of continuous subcutaneous insulin infusion (CSII) therapy on retinopathy in patients with Type 1 diabetes
    Khan, I.
    Hopley, D.
    Glover, L.
    Bett, S.
    Young, S.
    Ratcliffe, J.
    Martin, P.
    Krishnan, S.
    Bharaj, H.
    Banerjee, M.
    DIABETIC MEDICINE, 2019, 36 : 73 - 73
12345